Skip to content
Assyro AI
FDA Orange Book ยท active-ingredient family

Clomipramine hydrochloride

Clomipramine hydrochloride: 1 brand, 21 generics; first approved Dec 29, 1989; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 21 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
21
Listed patents
0
Presentations
66

Brand (NDA) products

Originator applications
Ask AI
  • NDA 01990619893 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB

Generic (ANDA) products (21)

Abbreviated applications
Ask AI
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21644020233 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21182220213 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21389720203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21228520203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21321920203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21322120203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21065320203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21136420203 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21221820193 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 21176720193 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 20929420183 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 20863220183 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 20896120173 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07475119983 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07494719983 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07495819973 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07495319973 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07484919973 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07469419963 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07460019963 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALDiscontinued-
    50MGCAPSULEORALDiscontinued-
    75MGCAPSULEORALDiscontinued-
  • CLOMIPRAMINE HYDROCHLORIDE
    ANDA 07436419963 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    25MGCAPSULEORALRxAB
    50MGCAPSULEORALRxAB
    75MGCAPSULEORALRxAB

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
37 yr 5 mo ago
Most recent approval
3 yr 8 mo ago

Approvals span 1989โ€“2023 across 22 FDA applications.

Brand (NDA) 15%
Generic (ANDA) 2195%

Clomipramine hydrochloride: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Clomipramine hydrochloride

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo